GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » IMRIS Inc (FRA:9IM) » Definitions » Selling and Marketing Expense

IMRIS (FRA:9IM) Selling and Marketing Expense : €5.42 Mil (TTM As of Dec. 2014)


View and export this data going back to . Start your Free Trial

What is IMRIS Selling and Marketing Expense?

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services. IMRIS's Selling and Marketing Expense for the three months ended in Dec. 2014 was €1.32 Mil. Its Selling and Marketing Expense for the trailing twelve months (TTM) ended in Dec. 2014 was €5.42 Mil.

IMRIS Selling and Marketing Expense Historical Data

The historical data trend for IMRIS's Selling and Marketing Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IMRIS Selling and Marketing Expense Chart

IMRIS Annual Data
Trend Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14
Selling and Marketing Expense
Get a 7-Day Free Trial Premium Member Only 6.89 7.01 7.49 7.29 5.78

IMRIS Quarterly Data
Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14
Selling and Marketing Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.12 1.23 1.48 1.39 1.32

IMRIS Selling and Marketing Expense Calculation

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services.

Selling and Marketing Expense for the trailing twelve months (TTM) ended in Dec. 2014 adds up the quarterly data reported by the company within the most recent 12 months, which was €5.42 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IMRIS Selling and Marketing Expense Related Terms

Thank you for viewing the detailed overview of IMRIS's Selling and Marketing Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

IMRIS (FRA:9IM) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » IMRIS Inc (FRA:9IM) » Definitions » Selling and Marketing Expense
Comparable Companies
XKRX:238120 IVOB TSXV:TLT OSTO:CLS B BKK:BIZ TSXV:LXG ROCO:1799 XKRX:115480 IGNG XPAR:SSI ASX:RSH ROCO:6734 XKRX:056090 LSE:POLX IRIX PAVM LSE:AVCT LSE:IHC XCNQ:BLO XTER:GME
Traded in Other Exchanges
N/A
Address
100-1370 Sony Place, Winnipeg, MB, CAN, R3T 1N5
Website
http://www.imris.com
IMRIS Inc designs, manufactures and markets Image-guided therapy systems that improves the effectiveness of therapy delivery. Its main product is the Visius surgical theater. The company provides its products to hospitals that deliver clinical services to patients in the neurosurgical, spinal, cerebrovascular and cardiovascular markets. The firm is focused on bringing enhanced visualization to the point of therapy delivery and is spread across Canada, United States, Europe and the Middle East and Asia-Pacific.

IMRIS (FRA:9IM) Headlines

No Headlines